CIK 0001455365 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy Director bought 3,000 shares at $12.00 ($36,000)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 190,000 shares at $12.00 ($2,280,000)
- 4 Open-market buy Director bought 190,000 shares at $12.00 ($2,280,000)
- 4 Open-market sale 10% owner sold 33.09 shares at $12.00 ($397)
- 4 Open-market sale 10% owner sold 74.05 shares at $12.00 ($889)
- 4 Open-market sale Director sold 11.74 shares at $12.00 ($141)
- 4 Open-market buy CEO & President bought 12,500 shares at $12.00 ($150,000)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $12.00 ($60,000)
- 8-K Event Bylaws or fiscal year change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
Page 13 of 16 · 303 filings